CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global CAR-T Therapy market.
Description: Where is the largest and fastest growing market for the CAR-T therapy market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global CAR-T therapy market opportunities and strategies to 2030 report answers all these questions and many more.
The report covers the following chapters
• Executive Summary – The executive summary section of the report gives a brief overview and summary of the report • Report Structure – This section gives the structure of the report and the information covered in the various sections. • Introduction – The introduction section of the report gives brief introduction about segmentation by geography and segmentation by target antigen and by application. • Market Characteristics – The market characteristics section of the report defines and explains the CAR-T therapy market. This chapter also defines and describes products covered in the report. • Customer Information – This chapter covers recent customers’ trends/preferences in the global CAR-T therapy market • Trends And Strategies – This chapter describes the major trends shaping the global CAR-T therapy market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities. • COVID Impact Analysis – This section provides an insight on how the pandemic is impacting the CAR-T therapy market. • Global Market Size And Growth – This section contains the global historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods. • Regional Analysis – This section contains the historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values and growth and market share comparison by region. • Segmentation – This section contains the market values (2015-2030) and analysis for different segments. • Regional Market Size and Growth – This section contains the region’s market size (2019), historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies. • Competitive Landscape – This section covers details on the competitive landscape of the global CAR-T therapy market, estimated market shares and company profiles for the leading players. • Pipeline Analysis – This chapter covers information about the drugs currently in pipeline • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years. • Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years. • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for CAR-T therapy companies in terms of product offerings, geographic expansion, marketing strategies and target groups. • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
The global CAR-T therapy market is segmented into – By Target Antigen: CD19 Therapy; CD22 Therapy; BCMA Therapy; Others By Application: Acute Lymphoblastic Leukemia; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Chronic Lymphocytic Leukemia; Multiple Myeloma; Others
Companies Mentioned: Gilead Sciences; Novartis AG
Countries: USA, France, Germany, UK, China, India, Indonesia, Japan, South Korea, Australia, Russia, Brazil
Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase • Outperform competitors using accurate up to date demand-side dynamics information. • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates. • Identify growth segments for investment. • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market. • Create regional and country strategies on the basis of local data and analysis. • Stay abreast of the latest customer and market research findings • Benchmark performance against key competitors. • Develop strategies based on likely future developments. • Utilize the relationships between key data sets for superior strategizing. • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis • Gain a global perspective on the development of the market.
Our reports have been used by over 10K customers, including:
272 pages •
By The Business Research Company
• Mar 2021
Antisense & RNAi Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global antisense & RNAi therapeutics market. Description: Where is the largest and fastest growing...
Executive Summary The mRNA technology finds its applications in many diseases including the Covid-19 vaccine. The market for mRNA is mostly driven by the Covid-19 vaccine besides its major usage in cancer therapies. With the mutation of the coronavirus and possible spread of variants of the virus, the mRNA companies are...
The global radiotherapy market is valued at USD 5.9 billion in 2021 and is expected to reach USD 7.3 billion by 2026, at a CAGR of 4.2% during the forecast period. The growth of this market is primarily driven by the rising burden of target diseases and increasing investments, funds, and grants for the development of novel products. Additionally,...
The global cancer cachexia market was valued at USD 2,256.35 million in 2020, and it is expected to reach USD 2,974.49 million by 2026, registering a CAGR of 4.47% during the forecast period. The outbreak of COVID-19 impacted the cancer cachexia market, as hospitals and healthcare services were significantly reduced due to social distancing...
The Veterinary Pain management market was valued at USD 1,197 million in 2020, and it is expected to reach USD 1,910 million in 2026, registering a CAGR of nearly 6.30% during the forecast period. The global outbreak of COVID-19 has impacted all industries including veterinary pain medicine. Pet parents are advised to keep a safe distance...
The peptide therapeutics market was valued at US$ 24,878.55 million in 2019 and is projected to reach US$ 50,003.15 million by 2027; it is expected to grow at a CAGR of 9.2% during 2020–2027. The growth of the peptide therapeutics market is mainly attributed to the growing investments on peptide therapeutics and increasing prevalence of metabolic...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global IV and Oral Iron Drugs Market Report
The global IV and oral iron drugs market by revenue is expected to grow at a CAGR of 11.6% during the period 2021–2026.
The global IV and oral iron drugs market is expected to grow due to the prevalence...
The global injectables market is estimated to reach US$759.61 billion in 2025, progressing at a CAGR of 10.95%, over the period 2021-2025. Factors such as increasing geriatric population, upsurge in demand for convenient drug delivery, expanding use of biologics, rising healthcare expenditure and surging incidence of cancer cases would drive...
The Multiple Sclerosis Therapeutics market was valued at US$ 24,026.90 million in 2019 and it is projected to reach US$ 39,223.59 million by 2027; it is expected to grow at a CAGR of 6.5% from 2020 to 2027. The growth of the multiple sclerosis therapeutics market is mainly attributed to factors, such as growing prevalence of multiple...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.